Antibodies, BispecificImmunotherapy, AdoptiveMolecular Targeted Therapy
Dr. Jay Michael S. Balagtas, MD
NPI1942498928PAC ID2163562497
- Publications
- 7
- Clinical trials
- 15
- Hospital affiliations
- 1
- Medical group
- 1
- Insurance carriers
- 10
- Practice address
- 725 Welch Road, Palo Alto, CA 94304
- Practice phone
- Call (650) 497-8000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Balagtas' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jay Michael S. Balagtas is a pediatric hematology and oncology physician in Palo Alto, California
Dr. Balagtas practices at Lucile Packard Children's Hospital Stanford in Palo Alto, California, part of Stanford University.
Dr. Balagtas' NPI, 1942498928, was assigned on October 4, 2007. Dr. Balagtas graduated from New York Medical College in 1998. Dr. Balagtas holds California license A93450.
NPI and contact details
- NPI
- 1942498928NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2163562497
- NPI enumeration date
- October 4, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (650) 497-8000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 54
- Medical school graduation
- 1998
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Jay Michael S. Balagtas practices at Lucile Packard Children's Hospital Stanford in Palo Alto, California
Dr. Balagtas' primary practice is Lucile Packard Children's Hospital Stanford, at 725 Welch Road, Palo Alto, CA 94304 in Santa Clara County. The practice phone is (650) 497-8000.
- Lucile Packard Children's Hospital Stanford725 Welch Road, Palo Alto, CA 94304 · Santa Clara CountyPhone(650) 497-8000
Source: Dmand AI Affiliation Data
Dr. Jay Michael S. Balagtas is affiliated with 1 site of care and 1 medical group
Dr. Balagtas' primary practice is Lucile Packard Children's Hospital Stanford in Palo Alto, California, part of Stanford University. The medical group on file is Lucile Packard Children's Hospital Stanford. Dr. Balagtas' employer is on file too: a hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Jay Michael S. Balagtas' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balagtas practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Lucile Packard Children's Hospital Stanford | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Balagtas practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Stanford University and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jay Michael S. Balagtas is one of 385 pediatric hematologys and oncology physicians in California
Pediatric hematology-oncology is Dr. Balagtas' primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Balagtas is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dr. Balagtas is licensed in California.
Specialties and state licenses
- Pediatric hematology and oncology, CaliforniaPrimary
Pediatric hematologys and oncology physicians near Dr. Balagtas
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
385pediatric hematologys and oncology physicians in California62pediatric hematologys and oncology physicians in Palo Alto49pediatric hematologys and oncology physicians at Lucile Packard Children's Hospital Stanford
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jay Michael S. Balagtas' patients have a median age of 14
Across all payers, Dmand AI patient panel data puts Dr. Balagtas' median patient age at 14, with 46% women.
Dr. Balagtas' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 14
Patient panel by sex, all payers
- Women46%
- Men53%
Source: Dmand AI Patient Panel Data
How Dr. Jay Michael S. Balagtas takes part in Medicare
Dr. Balagtas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
Dr. Jay Michael S. Balagtas has 7 publications on record
Dmand AI links 7 papers to Dr. Balagtas, published from 2010 to 2024. Dr. Balagtas' most frequent co-authors are Catherine Cogley Aftandilian, MD, Kara Lynn Davis, DO and Jonathan Mark Ducore, MD, MPH.
Papers7
Years published2010 to 2024
Dr. Balagtas' papers by year, 2010 to 2024
Dr. Balagtas' most frequent co-authors
- Catherine Cogley Aftandilian, MD1 shared paper
- Kara Lynn Davis, DO1 shared paper
- Jonathan Mark Ducore, MD, MPH1 shared paper
Recent publications by Dr. Balagtas
AnticoagulantsConsensusEvidence-Based Medicine
Diagnosis, DifferentialDiagnostic ImagingKidney Neoplasms
Pediatr Blood Cancer
Fatal OutcomeHemochromatosisIron Overload
See who Dr. Balagtas researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Balagtas works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jay Michael S. Balagtas has worked on 15 clinical trials
Dmand AI links Dr. Balagtas to 15 clinical trials, 6 of them phase 3 studies. 8 are still active or recruiting. Conditions studied include Medulloblastoma, Neuroblastoma and Precursor Cell Lymphoblastic Leukemia-Lymphoma. Children's Oncology Group sponsors the most, 10.
Clinical trials with Dr. Balagtas by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 3Phase 2: 3 trials
- 6Phase 3: 6 trials
- NonePhase 4: no trials
Conditions in Dr. Balagtas' trials
- Medulloblastoma
- Neuroblastoma
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Neuroectodermal Tumors, Primitive, Peripheral
- Angiolipoma
Investigators on the most trials with Dr. Balagtas
- Leo Mascarenhas, MD14 shared trials
- Wei-Ping Violet Shen, MD14 shared trials
- Jonathan Bernstein, MD13 shared trials
Recent clinical trials with Dr. Balagtas
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia (opens in a new tab)
Active, not recruitingPhase 1/2
Leukemia, Myeloid, Accelerated PhaseBlast CrisisBosutinib
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma (opens in a new tab)
Active, not recruitingPhase 3
Precursor T-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaBortezomibCyclophosphamideCytarabine
Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma (opens in a new tab)
CompletedPhase 2
OsteosarcomaNeoplasms, Bone TissueEribulin Mesylate
GanglioneuroblastomaNeuroblastomaDinutuximabIrinotecan HydrochlorideTemozolomide
Invasive Fungal InfectionsLeukemia, Myelomonocytic, AcuteFluconazoleCaspofungin Acetate
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Jay Michael S. Balagtas graduated from New York Medical College
Dr. Balagtas graduated from New York Medical College in 1998.
- Medical school
- Board certified in pediatric hematology-oncology
Source: Dmand AI Professional Profile Data
Dr. Jay Michael S. Balagtas accepts plans from 10 insurance carriers
Dr. Balagtas is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.
- Aetna
- Elevance
- Blue Cross Blue Shield of Michigan
- Blue Cross Blue Shield of Massachusetts
- HCSC
- Regence Health Plans
- United Healthcare
- Blue Cross and Blue Shield of Kansas City
- +2 more carriersWith a free account
Plan types Dr. Balagtas accepts, by number of carriers
- Medicare7
- PPO6
- HMO4
- POS4
- EPO3
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Jay Michael S. Balagtas's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jay Michael S. Balagtas
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jay Michael S. Balagtas' NPI number?
Dr. Jay Michael S. Balagtas' NPI number is 1942498928. It was assigned on October 4, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Jay Michael S. Balagtas?
Dr. Jay Michael S. Balagtas is a pediatric hematology and oncology physician in Palo Alto, California. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Jay Michael S. Balagtas practice?
Dr. Balagtas practices at 725 Welch Road, Palo Alto, CA 94304. Dr. Balagtas' primary practice is Lucile Packard Children's Hospital Stanford in Palo Alto, California, part of Stanford University.
What is Dr. Jay Michael S. Balagtas' office phone number?
The practice phone on file for Dr. Balagtas is (650) 497-8000.
What is Dr. Jay Michael S. Balagtas' medical license number?
Dr. Balagtas holds California license A93450.
Which hospitals is Dr. Jay Michael S. Balagtas affiliated with?
Dr. Balagtas practices at Lucile Packard Children's Hospital Stanford in Palo Alto, California.
What medical group is Dr. Jay Michael S. Balagtas part of?
Dr. Balagtas is linked to Lucile Packard Children's Hospital Stanford.
Does Dr. Jay Michael S. Balagtas accept Medicare?
Yes. CMS lists Dr. Balagtas as accepting Medicare assignment.
Is Dr. Jay Michael S. Balagtas board certified?
Yes. Dr. Balagtas is board certified in pediatric hematology-oncology by the American Board of Pediatrics.
Where did Dr. Jay Michael S. Balagtas go to medical school?
Dr. Balagtas graduated from New York Medical College in 1998.
Show 4 more questionsShow fewer questions
How long has Dr. Jay Michael S. Balagtas been practicing?
Dr. Balagtas graduated from medical school in 1998, 28 years ago.
Does Dr. Jay Michael S. Balagtas do research?
Dmand AI links 7 publications to Dr. Balagtas, published from 2010 to 2024. Dr. Balagtas has worked on 15 clinical trials.
Who does Dr. Jay Michael S. Balagtas publish with?
Dr. Balagtas' most frequent co-authors are Catherine Cogley Aftandilian, MD (1 shared paper), Kara Lynn Davis, DO (1 shared paper) and Jonathan Mark Ducore, MD, MPH (1 shared paper).
What insurance does Dr. Jay Michael S. Balagtas accept?
Dr. Balagtas is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card